|
Press Releases |
|
|
|
Wednesday, June 15, 2022 |
|
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM |
On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. ("Innovent") and PT Etana Biotechnologies Indonesia ("Etana"), jointly announced that the Indonesian Food and Drugs Authority (BPOM) had approved Bevagen (bevacizumab biosimilar) more info >> |
|
Thursday, June 9, 2022 |
|
Legend Capital Portfolio: Japan's No.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange |
On June 8th 2022, Legend Capital's portfolio company ANYCOLOR, a leading Virtual YouTuber (VTuber) management company in Japan, was listed on the Tokyo Stock Exchange. more info >> |
|
Friday, May 27, 2022 |
|
Legend Capital's Portfolio Company Feima Robotics Assists China's 38th Antarctic Expedition with a Series of Civilian UAV Products |
On April 26, 2022, the expedition ship Xuelong 2 for China's 38th Antarctic expedition berthed at the Shanghai base dock. So far, China's 38th Antarctic expedition, which lasted 174 days and traveled more than 33,000 nautical miles, has ended successfully. more info >> |
|
Wednesday, April 27, 2022 |
|
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis |
Legend Capital's portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage M201 program from Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and other viral diseases. more info >> |
|
Tuesday, April 26, 2022 |
|
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022 |
Legend Capital's portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for initial public offering (IPO) on the KOSDAQ market, and it plans to submit a registration statement within the second quarter of 2022. more info >> |
|
Sunday, April 24, 2022 |
|
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China |
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital's co-founded company Innostellar Biotherapeutics more info >> |
|
Thursday, April 7, 2022 |
|
Legend Capital's Portfolio Company Recbio Lists on HKEX Successfully |
On 31 March 2022, Legend Capital's portfolio company Jiangsu Recbio Technology Co., Ltd. ("Recbio", stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange. more info >> |
|
Thursday, March 3, 2022 |
|
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital |
On 28 February 2022, Inceptio Technology, an autonomous driving truck technology and operation company, announced its completion of a US$188 million Series B+ equity financing, jointly led by Legend Capital. more info >> |
|
Wednesday, March 2, 2022 |
|
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital |
On 28 February 2022, Inceptio Technology, an autonomous driving truck technology and operation company, announced its completion of a US$188 million Series B+ equity financing, jointly led by Legend Capital. more info >> |
|
Thursday, December 16, 2021 |
|
Legend Capital's Portfolio Company SF Intra-city Successfully Listed on HKEx |
On December 14, Legend Capital portfolio company SF Intra-city (09699.HK) successfully listed on the Hong Kong Stock Exchange (HKEx). SF Intra-city issued a total of 131 million shares at an issue price of HK$16.42 per share. The net proceeds from the global offering are approximately HK$2031.3 million. more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
POWERSCHOOL HOLDINGS, INC. (PWSC): Kaplan Fox & Kilsheimer LLP Investigates POWERSCHOOL and Encourages Investors to Contact the Firm
Apr 20, 2024 11:16 HKT/SGT
|
|
|
JABIL (JBL): JABIL DISCLOSES INVESTIGATION AND PLACES CEO ON PAID LEAVE - Kaplan Fox & Kilsheimer LLP Investigates and Encourages Investors to Contact the Firm
Apr 20, 2024 10:00 HKT/SGT
|
|
|
Phish Live at Sphere: Moment Factory Harnesses Sphere's Next-Generation Technologies to Reimagine Concert Experience
Apr 20, 2024 09:00 HKT/SGT
|
|
|
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
Apr 20, 2024 01:00 HKT/SGT
|
|
|
Brawijaya University researcher develops honey-processing tech
Apr 19, 2024 23:00 HKT/SGT
|
|
|
UK's Largest EV Show Returns for 4th Edition Driving Innovation with Policy Leaders, Product Launches, and EV Innovations
Apr 19, 2024 20:03 HKT/SGT
|
|
|
GLOBE LIFE (GL): Kaplan Fox & Kilsheimer LLP Investigates GLOBE LIFE and Encourages Investors to Contact the Firm
Apr 19, 2024 20:00 HKT/SGT
|
|
|
SMC Announces Marketing Agreement with Plato Technologies. Inc.
Apr 19, 2024 16:03 HKT/SGT
|
|
|
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
|
|
|
Prestigious titles for top developers at the 14th PropertyGuru Asia Property Awards (Singapore)
Apr 19, 2024 11:30 HKT/SGT
|
|
|
Revolutionizing Tomorrow: Uniting Visionaries at the 2024 Digital Transformation Summit Philippines
Apr 19, 2024 11:23 HKT/SGT
|
|
|
22nd Edition of Cyber Security Summit: Thailand to Convene Esteemed Panel of Industry Leaders
Apr 19, 2024 10:11 HKT/SGT
|
|
|
The Rapidly Evolving Real Estate Landscape: Redefine Real Estate Summit Connects Key Players in South East Asia
Apr 19, 2024 10:11 HKT/SGT
|
|
|
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
|
|
|
Rapid Evolution in Philippines' BFSI Sector: BFSI IT Summit 2024 to Illuminate Transformation
Apr 19, 2024 08:02 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|